115 related articles for article (PubMed ID: 23939157)
21. [Expression of TGF-beta1 and E-cadherin in primary and metastatic ovarian carcinoma].
Fan DM; Shi HR; Chen ZM; Liu HN; Zhang RT
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1355-8. PubMed ID: 20584638
[TBL] [Abstract][Full Text] [Related]
22. A comparison of Twist and E-cadherin protein expression in primary non-small-cell lung carcinoma and corresponding metastases.
Wang G; Dong W; Shen H; Mu X; Li Z; Lin X; Liu Y; Du J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):1028-32. PubMed ID: 21376622
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone.
Saha B; Arase A; Imam SS; Tsao-Wei D; Naritoku WY; Groshen S; Jones LW; Imam SA
Prostate; 2008 Jan; 68(1):78-84. PubMed ID: 18008331
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites.
Mitselou A; Batistatou A; Nakanishi Y; Hirohashi S; Vougiouklakis T; Charalabopoulos K
Histol Histopathol; 2010 Oct; 25(10):1257-67. PubMed ID: 20712010
[TBL] [Abstract][Full Text] [Related]
25. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML
Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
[TBL] [Abstract][Full Text] [Related]
26. High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma.
Guarch R; Lawrie CH; Larrinaga G; Angulo JC; Pulido R; López JI
Ann Diagn Pathol; 2018 Jun; 34():27-30. PubMed ID: 29661723
[TBL] [Abstract][Full Text] [Related]
27. Expression of cadherin-8 in renal cell carcinoma and fetal kidney.
Blaschke S; Mueller CA; Markovic-Lipkovski J; Puch S; Miosge N; Becker V; Mueller GA; Klein G
Int J Cancer; 2002 Oct; 101(4):327-34. PubMed ID: 12209956
[TBL] [Abstract][Full Text] [Related]
28. Research Advances in CKLF-like MARVEL Transmembrane Domain-containing Family in Non-small Cell Lung Cancer.
Wu K; Li X; Gu H; Yang Q; Liu Y; Wang L
Int J Biol Sci; 2019; 15(12):2576-2583. PubMed ID: 31754330
[TBL] [Abstract][Full Text] [Related]
29. Cadherin-11 in renal cell carcinoma bone metastasis.
Satcher RL; Pan T; Cheng CJ; Lee YC; Lin SC; Yu G; Li X; Hoang AG; Tamboli P; Jonasch E; Gallick GE; Lin SH
PLoS One; 2014; 9(2):e89880. PubMed ID: 24587095
[TBL] [Abstract][Full Text] [Related]
30. [Expression of Ezrin and E-cadherin in nasopharyngeal carcinoma and its significance].
Wang L; Gao Y; Tu Q; Hong J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 35(9):969-75. PubMed ID: 20871163
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
Ozgüven BY; Karaçetin D; Kabukçuoğlu F; Taşkin T; Yener Ş
Pol J Pathol; 2011; 62(1):19-24. PubMed ID: 21574102
[TBL] [Abstract][Full Text] [Related]
32. [Chromophobe renal cell carcinoma: a clinicopathologic study and immunophenotypes of 42 cases].
Zhang W; Yu WJ; Jiang YX; Li YJ; Han F; Liu Y; Han ZL
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):76-80. PubMed ID: 22455881
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.
Krishnamachary B; Zagzag D; Nagasawa H; Rainey K; Okuyama H; Baek JH; Semenza GL
Cancer Res; 2006 Mar; 66(5):2725-31. PubMed ID: 16510593
[TBL] [Abstract][Full Text] [Related]
34. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases.
Taki A; Nakatani Y; Misugi K; Yao M; Nagashima Y
Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617
[TBL] [Abstract][Full Text] [Related]
35. E-cadherin and beta-catenin loss of expression related to bone metastasis in prostate cancer.
Pontes J; Srougi M; Borra PM; Dall' Oglio MF; Ribeiro-Filho LA; Leite KR
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):179-84. PubMed ID: 18685493
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic correlations of liver kinase B1, E-cadherin, and N-cadherin expression in non-small cell lung cancer.
Liu S; Miao Y; Fan C; Liu Y; Yu J; Zhang Y; Dai S; Wang E
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):334-40. PubMed ID: 23235348
[TBL] [Abstract][Full Text] [Related]
37. Levels of angiogenesis and expression of angiogenesis-related genes are prognostic for organ-specific metastasis of renal cell carcinoma.
Fukata S; Inoue K; Kamada M; Kawada C; Furihata M; Ohtsuki Y; Shuin T
Cancer; 2005 Mar; 103(5):931-42. PubMed ID: 15685621
[TBL] [Abstract][Full Text] [Related]
38. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
Tang XJ; Zhou QH; Zhang SF; Liu LX
Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
[TBL] [Abstract][Full Text] [Related]
39. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
40. Relationship between expressions of E-cadherin and alpha-catenin and biological behaviors of human pancreatic cancer.
Li YJ; Meng YX; Ji XR
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):471-7. PubMed ID: 14599963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
